Singapore: Spinifex Pharmaceuticals, an Australian pain drug development company, announced that the first set of patie...
Singapore: Australia-based Reva Medical has initiated enrolment of patients for its ReZolve 2 bioresorbable scaffold at ...
Singapore: Australian company CSL Behring has submitted a variation application to the European Medicines Agency (EMA) f...
Singapore: A treatment for patients with chronic myeloid leukaemia (CML) and Philadelphia chromosome positive acute lymp...
Singapore: The Asia-Pacific (APAC) breast cancer market is set to experience considerable expansion from $1.9 billion in...
Singapore: Researchers at the Centre for Vision Research from the Westmead Millennium Institute for Medical Research (WM...
Singapore: Regenerative medicine company, Orthocell, has been granted a patent in Canada covering the combination of bio...
Singapore: Bioxyne has entered into a non-binding term sheet for the proposed acquisition of 100 percent of the shares a...
Singapore: Australia-based Clinuvel has developed SCENESSE, its proprietary first-in-class photo protective drug, for in...
Singapore: Sienna Cancer Diagnostics, Melbourne-based biotechnology company focused on developing novel in-vitro diagnos...
Singapore: A novel technology for aiding the diagnosis of Cancers of Unknown Primary (CUP), by Circadian Technologies, w...
Singapore: The Queensland Government has announced a collaboration with the US pharmaceutical and healthcare giant, John...
Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...
Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in t...
Singapore: Singapore's Inex Innovations Exchange, a fetal health diagnostics company, signed a distribution agreement fo...
There is no doubt that the world is still in a delicate financial balance, with no significant chance of that improving ...
Singapore: Lignol Energy, a leading technology company in the advanced biofuels and renewable chemicals sectors, will in...
Singapore: Nohla Therapeutics, a developer of cellular therapies for haematological disorders and immunological diseases...
